Major
clopidogrel × ibuprofen
Antiplatelet agents – P2Y12 receptor inhibitors×Non-steroidal anti-inflammatory drugs (NSAIDs)
Sources
- ESC: 2023 ESC Guidelines for the management of acute coronary syndromes (2023)— Eur Heart J 2023;44(38):3720–3826
Antiplatelet agents – P2Y12 receptor inhibitors×Non-steroidal anti-inflammatory drugs (NSAIDs)